Neoadjuvant chemoradiotherapy for esophageal/ gastroesophageal carcinoma

Journal of Gastrointestinal Oncology

Hector R. Nava²  Leayn Flaherty¹  Kilian S. May¹  Mei Ka Fong¹  Usha Malhotra¹  Graham W. Warren¹  Steven J. Nurkin²  Charles M. LeVea¹  Sai Yendamuri¹  Adrienne Groman¹  Timothy A. Platz² 

[1] Surgical Oncology, 2Pharmacology, 3Biostatistics, 4Radiation Oncology, 5Medical Oncology, 6Pathology, 7Thoracic Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USASurgical Oncology, 2Pharmacology, 3Biostatistics, 4Radiation Oncology, 5Medical Oncology, 6Pathology, 7Thoracic Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USASurgical Oncology, 2Pharmacology, 3Biostatistics, 4Radiation Oncology, 5Medical Oncology, 6Pathology, 7Thoracic Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA

关键词: Esophageal adenocarcinoma;    trimodality therapy;    standard uptake value (SUV);    pathologic response;   

DOI  :  10.3978/j.issn.2078-6891.2013.007

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown